Startseite Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
Artikel Open Access

Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2

  • Yong-Hua Duan , Fei Yuan , Shi-Biao Hu , Jiang Bian und Ya-Fei Guo ORCID logo EMAIL logo
Veröffentlicht/Copyright: 24. Januar 2023

Abstract

C11H14N2S2, monoclinic, I2/a (no. 15), a = 11.4278(8) Å, b = 8.5816(6) Å, c = 25.1115(18) Å, β = 95.173(6)°, V = 2452.6(3) Å3, Z = 8, Rgt(F) = 0.0416, wRref(F2) = 0.1169, T = 293 K.

CCDC no.: 2223179

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: White block
Size: 0.20 × 0.10 × 0.10 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.40 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.1°, >99%
N(hkl)measured, N(hkl)unique, Rint: 5764, 2844, 0.016
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 2294
N(param)refined: 139
Programs: CrysAlisPRO [1], Olex2 [2], SHELX [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
C1 0.4177 (2) 0.4056 (3) 0.25815 (10) 0.0617 (6)
H1 0.3805 0.4617 0.2298 0.074*
C2 0.3508 (2) 0.3366 (3) 0.29530 (10) 0.0585 (6)
H2A 0.2695 0.3476 0.2915 0.070*
C3 0.40300 (19) 0.2524 (3) 0.33754 (10) 0.0540 (5)
H3 0.3577 0.2060 0.3621 0.065*
C4 0.52430 (17) 0.2378 (2) 0.34288 (8) 0.0424 (4)
C5 0.59131 (17) 0.3078 (2) 0.30550 (8) 0.0425 (4)
C6 0.5384 (2) 0.3922 (3) 0.26267 (9) 0.0567 (6)
H6 0.5830 0.4383 0.2378 0.068*
C7 0.69924 (17) 0.1720 (2) 0.37898 (8) 0.0409 (4)
C8 0.9364 (2) 0.4173 (3) 0.43259 (11) 0.0708 (8)
H8A 0.9020 0.4527 0.3984 0.106*
H8B 0.9881 0.4962 0.4484 0.106*
H8C 0.8755 0.3968 0.4556 0.106*
C9 1.00576 (19) 0.2688 (2) 0.42528 (8) 0.0470 (5)
C10 1.0997 (2) 0.2977 (4) 0.38681 (12) 0.0755 (8)
H10A 1.1402 0.2021 0.3810 0.113*
H10B 1.1547 0.3738 0.4019 0.113*
H10C 1.0631 0.3354 0.3534 0.113*
C11 1.0612 (2) 0.2080 (3) 0.47855 (10) 0.0653 (7)
H11A 1.0014 0.1945 0.5027 0.098*
H11B 1.1186 0.2813 0.4934 0.098*
H11C 1.0985 0.1097 0.4732 0.098*
N1 0.58840 (14) 0.1598 (2) 0.38442 (7) 0.0481 (4)
N2 0.92808 (14) 0.14896 (19) 0.39748 (7) 0.0434 (4)
H2 0.9451 0.1087 0.3678 0.052*
S1 0.73913 (4) 0.27375 (6) 0.32288 (2) 0.04678 (17)
S2 0.80602 (5) 0.09427 (7) 0.42556 (2) 0.05143 (18)

Source of material

2-Mercaptobenzothiazole (2 mmol) was added to a solution of tert-butylamine (20 mmol) in the presence of self-prepared N-doped carbon supported cobalt catalyst [4]. The mixture was stirred at 45 °C under oxygen atmosphere for 4 h. The mixture was filtered and the filtrate was added to water (10 mL). The resulting mixture was extracted with ethylether (10 mL) for three times. The combined organic layers were washed with water and brine, dried over anhydrous MgSO4 and concentrated under reduced pressure. After removal of the solvent, the residue was purified by flash column chromatography on silica gel with petroleum ether/ethyl acetate to give the desired product as a white solid. Single crystals were obtained by crystallization of the title compound from ethyl acetate. Melting point: 104–106 °C. 1H NMR (400 MHz, CDCl3, 298 K) d 7.81 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.40–7.36 (m, 1H), 7.27–7.24 (m, 1H), 3.44 (s, 1H), 1.27 (s, 9H). 13C{ 1 H} NMR (101 MHz, CDCl3) d 181.4, 155.1, 134.9, 125.8, 123.5, 121.5, 121.0, 55.5, 29.0.

Experimental details

Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.

Comment

Sulfenamide compounds containing S–N bonds are important bioactive frameworks with a wide range of applications in organic synthesis [5], pharmaceuticals [6], fine chemicals [7] and materials science [8]. Studies have shown that sulfenamides are known for their therapeutic effects in improving endothelial function and plasma hemostasis [9]. In addition, 2-benzothiazole sulfenamides including N-tert-butylbenzothiazole-2-sulfenamide, N-cyclohexylbenzothiazole-2-sulfenamide and others are widely used as accelerators for rubber vulcanization in industry [1011]. In this paper, we investigated the synthesis and crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl) thiohydroxylamine, a sulfenamide used as typical rubber vulcanization accelerator.

The molecular structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl) thiohydroxylamine is shown in the figure. The asymmetric unit of the title structure contains one molecule The single crystal structure of the title compound shows the tert-butylamine and the 2-mercaptobenzothiazole groups are linked by the S–N bonds. The bond length of the N2–S2 (1.685 Å) is close to the typical N–S bond (1.695 Å) [12], which indicates that the S–N bond constructs in the compound. The 2-mercaptobenzothiazole together with nitrogen atom is almost strictly planar, whereby the largest deviation for the N2 atom from the 2-mercaptobenzothiazole plane is 0.149 Å. The dihedral angle between the N2–S2–C7 plane and C9–N2–S2 plane of the major components of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl) thiohydroxylamine were found to be 68.26°. The C9–N(2)–S(2)–C(7) torsion angles are – 111.74(15). The N(2)–S(2)–C(7) and C9–N(2)–S(2) bond angle are 99.68(9)° and 118.47(13)°. Within the tert-butylamine unit, the bond angles of C(8)–C(9)–C(10), C(8)–C(9)–C(11), C(10)–C(9)–C(11) are 110.1(2), 111.20(19), 110.6(2). The bond lengths of C(9)–C(10), C(9)–C(8), C(9)–C(11) are 1.520(3), 1.527(3), 1.520(3) Å respectively. The bond lengths and angles are all in the expected ranges [12].

The complete set of X-ray diffraction data for the title compound was deposited to the Cambridge Crystallographic Data Centre (CCDC entry no. 2223179).


Corresponding author: Ya-Fei Guo, School of Chemistry and Chemical Engineering, Henan University of Science and Technology, Luoyang, Henan 471003, P. R. China, E-mail:

Funding source: Natural Science Foundation of Henan Province

Award Identifier / Grant number: 222300420150

Funding source: Programs for Science and Technology Development of Henan Province

Award Identifier / Grant number: 212102210650

Award Identifier / Grant number: 212102210601

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Natural Science Foundation of Henan Province (No. 222300420150), Programs for Science and Technology Development of Henan Province, China (Nos. 212102210650 and 212102210601).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Oxford Diffraction. CrysAlisPRO (Version 1.171.33.42); Oxford Diffraction Ltd.: Oxford, UK, 2009.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

4. Guo, Y.-F., Dong, L., Ma, J.-Y., Feng, S.-X., Duan, Y.-H., Xu, B.-H. Sustainable aerobic oxidative coupling of thiols and amines for selective formation of sulfenamides using MOF-derived cobalt nanoparticles supported on N-doped carbon. New J. Chem. 2022, 46, 23321–23327; https://doi.org/10.1039/d2nj01356h.Suche in Google Scholar

5. Li, R., Zhou, Y., Yoon, K. Y., Dong, Z., Dong, G. Sulfenamide-enabled ortho thiolation of aryl iodides via palladium/norbornene cooperative catalysis. Nat. Commun. 2019, 10, 3555; https://doi.org/10.1038/s41467-019-11398-0.Suche in Google Scholar PubMed PubMed Central

6. Shang, J.-L., Guo, H., Li, Z.S., Ren, B., Li, Z.-M., Dai, H.-q., Zhang, L.-X., Wang, J.-G. Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents. Bioorg. Med. Chem. Lett. 2013, 23, 724–727; https://doi.org/10.1016/j.bmcl.2012.11.103.Suche in Google Scholar PubMed

7. Ruiperez, F., Galdeano, M., Gimenez, E., Matxain, J. M. Sulfenamides as building blocks for efficient disulfide-based self-healing materials. A quantum chemical study. ChemistryOpen 2018, 7, 248–255; https://doi.org/10.1002/open.201800003.Suche in Google Scholar PubMed PubMed Central

8. Mutlu, H., Theato, P. Making the best of polymers with sulfur–nitrogen bonds: from sources to innovative materials. Macromol. Rapid Commun. 2020, 41, 2000181; https://doi.org/10.1002/marc.202000181.Suche in Google Scholar PubMed

9. Markowicz-Piasecka, M., Huttunen, K. M., Broncel, M., Sikora, J. Sulfenamide and sulfonamide derivatives of Metformin – a new option to improve endothelial function and plasma haemostasis. Sci. Rep. 2019, 9, 6573; https://doi.org/10.1038/s41598-019-43083-z.Suche in Google Scholar PubMed PubMed Central

10. Nabil, H., Ismail, H., Azura, A. R. Optimisation of accelerators and vulcanising systems on thermal stability of natural rubber/recycled ethylene-propylene-diene-monomer blends. Mater. Des. 2014, 53, 651–661; https://doi.org/10.1016/j.matdes.2013.06.078.Suche in Google Scholar

11. Rong, G., Chen, Y., Wang, L., Li, J., Wang, J., Panzer, M. J., Pang, Y. A benzoxazole sulfenamide accelerator: synthesis, structure, property, and implication in rubber vulcanization mechanism. J. Appl. Polym. Sci. 2014, 131, 596–602; https://doi.org/10.1002/app.39699.Suche in Google Scholar

12. Brito, I., León, Y., Gacitúa, C., Arias, M., Wittke, M. The crystal structure of triphenylmethane-piperidine-sulfenamide. J. Chil. Chem. Soc. 2000, 45, 509–513.Suche in Google Scholar

Received: 2022-11-30
Accepted: 2023-01-10
Published Online: 2023-01-24
Published in Print: 2023-04-25

© 2022 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
  4. The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
  5. Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
  6. Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
  7. Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
  8. The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
  9. The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
  10. Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
  11. The crystal structure of strictic acid, C20H26O3
  12. Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
  13. The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
  14. The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
  15. Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
  16. Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
  17. Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
  18. Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
  19. Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
  20. Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
  22. Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
  23. Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
  24. Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
  25. Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  26. Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
  27. Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
  28. Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
  29. Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
  30. Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
  31. Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
  32. The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
  33. The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
  34. Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
  35. Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
  36. Crystal structure of niobium trigallide, NbGa3
  37. Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
  38. Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
  39. The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
  40. The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
  41. Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
  42. Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
  43. The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
  44. Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
  45. Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
  46. Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
  47. Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
  48. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
  49. The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
  50. Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
  51. Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
  52. Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
  53. Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
  54. Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
  55. The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
  56. Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
  57. The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
  58. Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
  59. Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
  60. Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
  61. Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
  62. Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
  63. Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
  64. Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
  65. Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
  66. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
  67. The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
  68. The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
  69. Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
  70. Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
  71. One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
  72. The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
  73. Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
  74. The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
  75. The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
  76. The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
  77. Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
  78. Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9
Heruntergeladen am 16.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0552/html
Button zum nach oben scrollen